Viewing Study NCT00621894


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-01-03 @ 4:40 AM
Study NCT ID: NCT00621894
Status: COMPLETED
Last Update Posted: 2024-12-16
First Post: 2008-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immune Thrombocytopenic Purpura View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune thrombocytopenic purpura View
None thrombopoietin mimetic View
None ITP View